For example, Srivatsa et al. (2017) found that EGFR-expressing myeloid cells are abundant in the colorectal tumor stroma, indicating that EGFR in tumor-associated myeloid cells may be a diagnostic biomarker for colorectal cancer (CRC). This evidence concerns the gene EGFR and neoplasm.